Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
161,976,581
-
Total 13F shares
-
171,898,581
-
Share change
-
+9,151,740
-
Total reported value
-
$1,979,809,998
-
Put/Call ratio
-
0%
-
Price per share
-
$11.53
-
Number of holders
-
224
-
Value change
-
+$100,139,847
-
Number of buys
-
119
-
Number of sells
-
103
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q2 2022
As of 30 Jun 2022,
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) was held by
224 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
171,898,581 shares.
The largest 10 holders included
BlackRock Inc., Sarissa Capital Management LP, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BROWN CAPITAL MANAGEMENT LLC, STATE STREET CORP, LSV ASSET MANAGEMENT, RENAISSANCE TECHNOLOGIES LLC, PUTNAM INVESTMENTS LLC, and CREDIT SUISSE AG/.
This page lists
224
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.